Drug intelligence / Profile preview

Prospera Pd-103

Development stage
Unknown
Lead developer
North American Scientific
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Interstitial
01

Overview

Prospera Pd-103 is a brachytherapy source consisting of a welded titanium capsule containing the radioisotope Palladium-103. The isotope is adsorbed onto resin or polystyrene beads within the capsule, which also includes gold beads or spheres that serve as x-ray markers for radiographic identification and localization. Manufactured by Brachytherapy Services, Inc. (Model MED3633), these seeds are primarily used for permanent interstitial implantation in localized tumors, most notably for the treatment of prostate cancer. The Palladium-103 isotope delivers localized radiation therapy by emitting low-energy X-rays (Auger electrons and X-rays) with a half-life of approximately 17 days, providing a high localized dose of radiation to the tumor while minimizing exposure to surrounding healthy tissue.

Brand names
Prospera Pd-103Prospera
Other names
Prospera 103PdProspera103PdProspera-103PdPalladium-103 seedPalladium103 seedPalladium 103 seed103Pd seed
02

Targets

DNA

Beyond the preview

Go deeper on Prospera Pd-103.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Prospera Pd-103.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call